Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Treasury Shares (2022 - 2025)

Historic Treasury Shares for SOPHiA GENETICS (SOPH) over the last 2 years, with Q3 2024 value amounting to -$719000.0.

  • SOPHiA GENETICS's Treasury Shares changed N/A to -$632000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$632000.0, marking a year-over-year change of. This contributed to the annual value of -$702000.0 for FY2024, which is 866.87% down from last year.
  • SOPHiA GENETICS's Treasury Shares amounted to -$632000.0 in Q3 2025.
  • SOPHiA GENETICS's 5-year Treasury Shares high stood at -$112000.0 for Q1 2023, and its period low was -$702000.0 during Q4 2024.
  • In the last 4 years, SOPHiA GENETICS's Treasury Shares had a median value of -$639000.0 in 2023 and averaged -$436000.0.
  • The largest annual percentage gain for SOPHiA GENETICS's Treasury Shares in the last 5 years was 1578.95% (2023), contrasted with its biggest fall of 45254.24% (2023).
  • Quarter analysis of 4 years shows SOPHiA GENETICS's Treasury Shares stood at -$117000.0 in 2022, then plummeted by 452.14% to -$646000.0 in 2023, then fell by 8.67% to -$702000.0 in 2024, then increased by 9.97% to -$632000.0 in 2025.
  • Its Treasury Shares was -$632000.0 in Q3 2025, compared to -$648000.0 in Q2 2025 and -$694000.0 in Q1 2025.